ArticleProstate international2025
Comparative outcomes of transurethral resection of the prostate in benign prostatic hyperplasia patients with and without upper urinary tract dilatation: a propensity score matching analysis.
Article in Prostate international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Four-year outcomes of water vapor thermal therapy for benign prostatic hyperplasia.Prostate international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Upper urinary system dilation appears to be a precursor to the progression to renal failure as a result of benign prostatic hyperplasia (BPH). This study aimed to compare the outcomes of transurethral resection of the prostate (TUR-P) between BPH patients who develop upper urinary tract dilation (UUTD) and those in the normal group. Materials and methods: Patients who underwent TUR-P for BPH diagnosis between 2019 and 2024 were included in the study. A propensity score matching was applied based on parameters such as age, International Prostate Symptom Score, prostate-specific antigen, prostate volume, serum creatinine, preoperative hemoglobin value, and presence of transurethral catheter. After the formation of the normal and UUTD patient groups, demographic and clinical data were compared. TUR-P outcomes, including International Prostate Symptom Score, clot retention, reoperation rates, blood transfusion rates, urinary retention rates, postoperative uroflow values, urodynamic requirements, and results were compared between the groups. Results: After propensity score matching, a total of 128 patients who underwent TUR-P due to BPH, comprising 64 patients with UUTD and 64 patients with normal findings, were retrospectively reviewed. Mean hemoglobin level after TUR-P for UUTD group was 12.7 ± 1.9 g/dl, and for the normal group, it was 13.2 ± 2.1 g/dl. Postoperative clot retention rate UUTD and normal group was 4.7% and 3.1%, respectively. Blood transfusion rate for the UUTD group was 4.7%, and for the normal group, it was 1.6%. Postoperative urinary retention rate was higher in the UUTD group (18.7 vs. 9.4, Conclusions: Although the rate of postoperative urinary retention is higher in patients with UUTD, which can lead to impaired kidney function during the course of BPH, TUR-P can be effectively performed without causing a significant increase in early or long-term complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.